This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
July 26, 2012 8:00 am ET
William H. Kucheman - Chief Executive Officer, Director and Member of Finance Committee
Jeffrey D. Capello - Chief Financial Officer and Executive Vice President
Michael F. Mahoney - President
Glenn J. Novarro - RBC Capital Markets, LLC, Research Division
James Francescone - Morgan Stanley, Research Division
Michael N. Weinstein - JP Morgan Chase & Co, Research Division
Bruce M. Nudell - Crédit Suisse AG, Research Division
Kristen M. Stewart - Deutsche Bank AG, Research Division
Daniel Sollof - Barclays Capital, Research Division
Kevin Strange - Wells Fargo Securities, LLC, Research Division
Ladies and gentlemen, thank you for standing by. Welcome to the Boston Scientific Q2 Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded. I would now like to turn the conference over to our host, Mr. Sean Wirtjes. Please go ahead.
Thank you, Linda. Good morning, everyone, and thanks for joining us. With me on today's call are Hank Kucheman, Chief Executive Officer; and Jeff Capello, Executive Vice President and Chief Financial Officer.
We issued a press release earlier this morning announcing our Q2 2012 results, which included key financials and reconciliations of the non-GAAP financial measures used in the release. We posted a copy of that press release, as well as reconciliations of the non-GAAP financial measures used in today's conference call to the comparable GAAP measures and other supporting schedules to the Investor Relations section of our website under the heading Financial Information.